Research & Development



  曹襄見雲瑯半天不說話,就嘿嘿笑道︰“挺周到的是吧?”   劉徹笑了,示意隋越給曹襄一杯茶。色天使在线影院超碰   最終,她也弄了一朵黃色牡丹從雲瑯窗前重新走了一遍。曰本高清一本道无码av   張安世不但要負責教導六個小的,還要執掌雲氏錢莊,這樣一來壓力不小。   雲瑯笑道︰“還有我的兩個老婆,每一個都是治病救人的國手,其中一個還有身孕,如果陛下需要她們出征,她們一定會為國舍命征戰,絕無二話!”52avav我爱aⅴ在线观看   桑弘羊看到這封奏折的時候,臉上的鄙夷之態無論如何都掩飾不住。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo